-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Consensus Rating of “Buy” from Brokerages
Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) have received an average recommendation of “Buy” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have covered the stock in […]
Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) have received an average recommendation of “Buy” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have covered the stock in […]
